^
Association details:
| Biomarker: | HER-2 positive |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug: | sabizabulin (VERU-111) (α-tubulin inhibitor, β-tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
1670 / 27 - Sabizabulin shows anti-cancer efficacy in HER2+ breast cancer and novel sabizabulin derivatives overcome paclitaxel-resistance in triple negative breast cancer
Published date:
03/15/2023
Excerpt:
Sabizabulin inhibits the primary tumor growth in an orthotopic HER2+ in vivo model…
